| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks
1 company
Tom C Thomas last filed a Form 4 in August 2024, as See Remarks at VINC. Tom C Thomas's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 219,935 shares of VINC. Net of sales, the VINC filings show accumulation of 15,000 shares.
Tom C Thomas has 12 Form 4 filings on record from March 2021 to August 2024, all as Vincerx Pharma (VINC), 2021–2024.
The 25 reported transactions were 14 option or other derivative awards, 7 dispositions back to the company and 4 open-market purchases.
Counted by filing, the open-market trades come to 4 purchases worth about $46K and no sales.
The largest open-market purchase was 2,000 shares of VINC at an average $12.58 on June 29, 2021, about $25K.
Shares as reported in the last Form 4 for each company; the most recent is from August 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2023 | VINC Vincerx Pharma, Inc. | See Remarks | Buy | 5,000 | $0.95 | $4,750.00 | +2.3% | |
| Dec 14, 2022 | VINC Vincerx Pharma, Inc. | See Remarks | Buy | 7,000 | $0.83 | $5,810.00 | +233.3% | |
| Dec 22, 2021 | VINC Vincerx Pharma, Inc. | See Remarks | Buy | 1,000 | $10.23 | $10,230.00 | +50.0% | |
| Jun 29, 2021 | VINC Vincerx Pharma, Inc. | See Remarks | Buy | 2,000 | $12.58 | $25,160.00 | New |